Sonodynamic Therapy Development for Bladder Cancer
Sonodynamic therapy (SDT) is a noninvasive ultrasound-triggered therapeutic strategy for site-specific treatment of tumors with great depth penetration such as bladder cancer. Alfa Cytology offers cutting-edge research services and essential platforms to help you stay ahead in the development of sonodynamic therapy for bladder cancer.
Introduction to Sonodynamic Therapy
In SDT, low-frequency (<3 MHz) and low-intensity (<3 W/cm2) ultrasound (US) are utilized to stimulate sonosensitizers for inducing the production of reactive oxygen species (ROS), thereby causing damage to tumor cells. Although the mechanisms of SDT and PDT are similar, SDT possesses several advantages over photo-triggered PDT.
- Firstly, the US employed in SDT is a mechanical wave capable of penetrating tissues up to several centimeters with reduced attenuation, enabling it to reach deep tumor sites.
- Secondly, by adjusting the frequencies and intensities of US, additional therapeutic effects can be achieved while precisely locating deep tumor tissue through controlled US conditions.
In general, SDT exhibits comparable noninvasive effects against cancer as PDT but offers superior deep penetration capabilities that enable accurate treatment of deep lesions and provide new options for clinical treatment.
Fig.1 Schematic illustration of SDT's possible mechanisms. (Pan, M., et al., 2023)
Our Services
To offer a comprehensive range of sonodynamic therapy development services, we ensure meticulous design and execution at every stage of the process. Our service encompasses the following detailed components.
Novel Therapy Development
At Alfa Cytology, we focus on advancing sonodynamic therapy by developing novel sonosensitizers and refining treatment protocols. Our research aims to enhance the efficacy and precision of SDT for bladder cancer, ensuring optimal therapeutic outcomes.
Sonosensitizer Screening and Optimization
Our state-of-the-art screening platforms allow for the identification and optimization of effective sonosensitizers. We assess various compounds for their ability to produce ROS upon ultrasound activation and their preferential accumulation in bladder cancer cells.
Ultrasound Parameter Optimization
We tailor ultrasound parameters, including frequency, intensity, and exposure time, to maximize the therapeutic efficacy while minimizing potential side effects. Our advanced ultrasound equipment ensures precise delivery and control of treatment conditions.
In Vitro and In Vivo Testing
Our comprehensive in vitro and in vivo testing services are designed to rigorously evaluate the safety and effectiveness of sonodynamic therapy.
In Vitro Cytotoxicity Testing
We conduct extensive in vitro studies to evaluate the cytotoxic effects of sonodynamic therapy on bladder cancer cell lines. These assays help determine the optimal conditions for inducing cancer cell death while sparing normal cells.
In Vivo Efficacy Studies
Our in vivo studies are designed to assess the therapeutic potential of sonodynamic therapy in animal models of bladder cancer. We evaluate tumor regression, survival rates, and potential side effects to ensure comprehensive preclinical validation.
Contact Us
At Alfa Cytology, we are committed to pushing the boundaries of cancer treatment. Our expertise and dedication to innovation make us the ideal partner for your sonodynamic therapy development needs. If you are looking to transform your bladder cancer research and achieve groundbreaking results, we are here to help. Contact us today to discuss how we can collaborate to advance your research and bring new hope to patients worldwide.
Reference
- Pan M., Hu D., and et al. Newly developed gas-assisted sonodynamic therapy in cancer treatment. Acta pharmaceutica Sinica. B, 2023, 13(7), 2926–2954.
For research use only. Not intended for any clinical use.
Related Services
